Synergistic induction of mitogen-activated protein kinase phosphatase-1 by thrombin and epidermal growth factor requires vascular endothelial growth factor receptor-2

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 10, 2010, Pages 1983-1989

  Chandrasekharan, Unni M ^a   Waitkus, Matthew ^a,b   Kinney, Corttrell M ^a,c   Walters Stewart, Alicia ^a   Dicorleto, Paul E ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endothelium; signal transduction; thrombin; vascular biology

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEINASE ACTIVATED RECEPTOR 1; STRESS ACTIVATED PROTEIN KINASE; THROMBIN; VASCULOTROPIN RECEPTOR 2; DUSP1 PROTEIN, HUMAN; DUSP1 PROTEIN, MOUSE; EGFR PROTEIN, HUMAN; EGFR PROTEIN, MOUSE; EPIDERMAL GROWTH FACTOR RECEPTOR; HEAT SHOCK PROTEIN 90; MESSENGER RNA; TRAP-1 PROTEIN, MOUSE; TRAP1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; DRUG EFFECTS; DRUG POTENTIATION; ENDOTHELIUM CELL; ENZYME INDUCTION; GENETICS; HUMAN; KINETICS; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; TRANSCRIPTION INITIATION;

ANIMALS; BASE SEQUENCE; CELL MOVEMENT; CELLS, CULTURED; DRUG SYNERGISM; DUAL SPECIFICITY PHOSPHATASE 1; ENDOTHELIAL CELLS; ENZYME INDUCTION; EPIDERMAL GROWTH FACTOR; HSP90 HEAT-SHOCK PROTEINS; HUMANS; KINETICS; MICE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, PAR-1; RNA, MESSENGER; SIGNAL TRANSDUCTION; THROMBIN; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77957713206     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.212399     Document Type: Article

References (29)

1. Chandrasekharan UM, Yang L, Walters A, Howe P, DiCorleto PE. Role of CL-100, a dual specificity phosphatase, in thrombin-induced endothe-lial cell activation. J Biol Chem. 2004;279:46678-46685.
2. Kinney CM, Chandrasekharan UM, Mavrakis L, DiCorleto PE. VEGF and thrombin induce MKP-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration. Am J Physiol Cell Physiol. 2008; 294:C241-C250.
3. Shen J, Chandrasekharan UM, Ashraf MZ, Long E, Morton RE, Liu Y, Smith JD, DiCorleto PE. Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis. Circ Res. 2010;106:902-910.
4. Keyse SM. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol. 2000;12:186-192.
5. Kinney CM, Chandrasekharan UM, Yang L, Shen J, Kinter M, McDermott MS, Dicorleto PE. Histone H3 as a novel substrate for MAP kinase phosphatase-1. Am J Physiol Cell Physiol. 2009;296:C242-C249.
6. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR. Dexameth-asone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol. 2002;22:7802-7811.
7. Liu Y, Gorospe M, Yang C, Holbrook NJ. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress: inhibition of c-Jun N-terminal kinase activity and AP-1-dependent gene activation. J Biol Chem. 1995;270:8377-8380.
8. Zhao Q, Wang X, Nelin LD, Yao Y, Matta R, Manson ME, Baliga RS, Meng X, Smith CV, Bauer JA, Chang CH, Liu Y. MAP kinase phos-phatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med. 2006;203:131-140.
9. Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato AC, Lang R. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med. 2006;203:15-20.
10. Co. Thrombin signalling and protease-activated receptors. Nature. 2000;407:258-264.
11. Moolenaar WH, van Meeteren LA, Giepmans BN. The ins and outs of lysophosphatidic acid signaling. Bioessays. 2004;26:870-881.
12. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 1996; 379:557-560.
13. Natarajan K, Berk BC. Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. Methods Mol Biol. 2006; 332:51-77.
14. Ohtsu H, Dempsey PJ, Frank GD, Brailoiu E, Higuchi S, Suzuki H, Nakashima H, Eguchi K, Eguchi S. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II. Arterioscler Thromb Vasc Biol. 2006;26: e133-e137.
15. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med. 2002;8:289-293.
16. Zhu W, Chandrasekharan UM, Bandyopadhyay S, Morris SM Jr, DiCorleto PE, Kashyap VS. Thrombin induces endothelial arginase through AP-1 activation. Am J Physiol Cell Physiol. 2010;298: C952-C960.
17. Prenzel N, Fischer OM, Streit S, Hart S, Ullrich A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer. 2001;8:11-31.
18. Nakai K, Yoneda K, Moriue T, Igarashi J, Kosaka H, Kubota Y. HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells. J Dermatol Sci. 2009;55: 170-178.
19. Rother E, Brandl R, Baker DL, Goyal P, Gebhard H, Tigyi G, Siess W. Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation. 2003;108:741-747.
20. Major CD, Santulli RJ, Derian CK, Andrade-Gordon P. Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice. Arterioscler Thromb Vasc Biol. 2003;23: 931-939.
21. Dreux AC, Lamb DJ, Modjtahedi H, Ferns GA. The epidermal growth factor receptors and their family of ligands: their putative role in athero-genesis. Atherosclerosis. 2006;186:38-53.
22. Holm PW, Slart RH, Zeebregts CJ, Hillebrands JL, Tio RA. Atherosclerotic plaque development and instability: a dual role for VEGF. Ann Med. 2009;41:257-264.
23. New DC, Wong YH. Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression. J Mol Signal. 2007;2:2.
24. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402:884-888.
25. Dhanasekaran DN. Transducing the signals: a G protein takes a new identity. Sci STKE. 2006;2006:pe31.
26. Schauwienold D, Sastre AP, Genzel N, Schaefer M, Reusch HP. The transactivated epidermal growth factor receptor recruits Pyk2 to regulate Src kinase activity. J Biol Chem. 2008;283:27748-27756.
27. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995;80:179-185.
28. Redondo P, Jimenez E, Perez A, Garcia-Foncillas J. N-acetylcysteine downregulates vascular endothelial growth factor production by human keratinocytes in vitro. Arch Dermatol Res. 2000;292:621-628. (Pubitemid 32112970)
29. Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, Cheresh DA. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature. 2008;456:809-813.